The long range goal of the proposed studies is to elucidate subcellular mechanisms by which certain cardioactive hormones and agents regulate myocardial cell function. The data we have obtained previously in this on-going project, in conjunction with that reported by others, has permitted us to establish a model for the interaction of phosphoinositide metabolism with the handling of Ca by the sarcoplasmic reticulum. Alpha-adrenergic hormones stimulate the breakdown of phosphatidylinositolbisphosphate to diacylglycerol and inositol trisphosphate. The IP3 stimulates the release of Ca from the SR and DAG activates protein kinase C. This response is modulated by an inhibition of phosphatidylinositol (PI) formation in the SR by elevated Ca2+ and, in addition, a reduction of IP3 is brought about by activation of IP3 phosphatases. Experiments are proposed to test various aspects of this model. Moreover, evidence that the SR also forms PIP and PIP2 as well as PI suggests that these substances may affect the SR Ca pump and this will be tested. Ca transport into the isolated SR is known to be stimulated by phosphorylation of the cytoplasmic segment of the membrane-bound protein phospholamban. Mild treatment with trypsin, which cleaves the cytoplasmic segment, also stimulates Ca transport but trypsin has no effect if the phospholamban has been phosphorylated prior to treatment. These observations support the hypothesis that unphosphorylated cytoplasmic segment has an inhibitory effect on Ca transport through some specific interaction with the surface of the SR membrane. This model will be tested in a number of ways including the following. The cytoplasmic segment and portions thereof will be chemically synthesized and the effects of their phosphorylated and unphosphorylated forms on trypsin activated SR will be determined. A panel of polyclonal antibodies will be obtained which will be antigenic to defined regions on the cytoplasmic segment of phospholamban. These will be used to monitor the release of the peptides upon activation of the Ca pump by treatment of membranes with different proteases as well as to determine which sequences are important in the Ca pump activation by antibody alone. These studies should allow detection of changes in the conformation of phospholamban upon phosphorylation and in the aging heart. In a third project, we will specifically test whether the in vitro increase in 32P incorporation into phospholamban in microsomes prepared from rat hearts from aged animals, previously observed, is due to a change in phospholamban.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
2R01HL015764-14
Application #
3335058
Study Section
Cardiovascular Study Section (CVA)
Project Start
1976-12-01
Project End
1992-06-30
Budget Start
1987-07-01
Budget End
1988-06-30
Support Year
14
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Mount Sinai School of Medicine
Department
Type
Schools of Medicine
DUNS #
City
New York
State
NY
Country
United States
Zip Code
10029
Kobrinsky, E M; Kirchberger, M A (2001) Evidence for a role of the sarcoplasmic/endoplasmic reticulum Ca(2+)-ATPase in thapsigargin and Bcl-2 induced changes in Xenopus laevis oocyte maturation. Oncogene 20:933-41
Antipenko, A; Spielman, A I; Kirchberger, M A (1999) Kinetic differences in the phospholamban-regulated calcium pump when studied in crude and purified cardiac sarcoplasmic reticulum vesicles. J Membr Biol 167:257-65
Antipenko, A Y; Spielman, A I; Kirchberger, M A (1999) Interactions of 6-gingerol and ellagic acid with the cardiac sarcoplasmic reticulum Ca2+-ATPase. J Pharmacol Exp Ther 290:227-34
Antipenko, A Y; Kirchberger, M A (1997) Membrane phosphorylation protects the cardiac sarcoplasmic reticulum Ca(2+)-ATPase against chlorinated oxidants in vitro. Cardiovasc Res 36:67-77
Antipenko, A Y; Spielman, A I; Sassaroli, M et al. (1997) Comparison of the kinetic effects of phospholamban phosphorylation and anti-phospholamban monoclonal antibody on the calcium pump in purified cardiac sarcoplasmic reticulum membranes. Biochemistry 36:12903-10
Antipenko, A Y; Spielman, A I; Kirchberger, M A (1997) Comparison of the effects of phospholamban and jasmone on the calcium pump of cardiac sarcoplasmic reticulum. Evidence for modulation by phospholamban of both Ca2+ affinity and Vmax (Ca) of calcium transport. J Biol Chem 272:2852-60
Lu, Y Z; Kirchberger, M A (1994) Effects of a nonionic detergent on calcium uptake by cardiac microsomes. Biochemistry 33:5056-62
Lu, Y Z; Xu, Z C; Kirchberger, M A (1993) Evidence for an effect of phospholamban on the regulatory role of ATP in calcium uptake by the calcium pump of the cardiac sarcoplasmic reticulum. Biochemistry 32:3105-11
Xu, Z C; Kirchberger, M A (1989) Modulation by polyelectrolytes of canine cardiac microsomal calcium uptake and the possible relationship to phospholamban. J Biol Chem 264:16644-51
Kasinathan, C; Xu, Z C; Kirchberger, M A (1989) Polyphosphoinositide formation in isolated cardiac plasma membranes. Lipids 24:818-23

Showing the most recent 10 out of 14 publications